Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Case Studies

  • Home
  • Blood product management
  • Case Studies
Better practice case studies

We have created case studies of areas of best practice in hospitals and laboratories across the country to improve and support blood management and patient blood management. You can use the relevant tools and approaches shown in these case studies in your own setting. Please consider all implications and risks specific to you where you would like to adapt practices for local use. 

 

Blood and Inventory Management 

NSW Health Pathology - North (Hunter)

The NSW Health Pathology – North (Hunter) operating at the John Hunter Hospital laboratory has had low blood product wastage rates for many years. It is their close management of inventory, quick release of product upon request, a team of involved haematologists and close management of age of product inventory that enables the team at John Hunter Hospital to consistently achieve these low wastage rates as well as be forerunners in the field of inventory management.

See the case study here: 

  • Better Practice Case Study: Hunter Area Pathology Service
    762.7 KB

SAN Pathology, NSW

San Pathology at Sydney Adventist Hospital has one of the lowest blood and blood product wastage rates of the Australian private health sector. San Pathology's practices of limiting cross matches to 24 hours, a focus on individual responsibility, close haematology support, ongoing training and regular audits allow them to achieve and maintain an excellent discard rate. It is clear that their culture and attitude towards treating blood as a precious resource has made a clear impact on the responsibility accepted by staff.

See the case study here: 

  • Better Practice Case Study - SAN Pathology
    762.49 KB

Pathology Queensland

Pathology Queensland comprises a hierarchical, networked system of 33 laboratories, providing pathology services to all Queensland Health public hospitals. This case study looks at the Pathology Queensland laboratories in the Royal Brisbane & Women’s, Redcliffe, Toowoomba and Townsville hospitals and illustrates some of the processes they have in place for blood management to minimise blood wastage, particularly around transfer arrangements and stock movement.

See the case study here:

  • Better Practice Case Study - Pathology Queensland
    470.36 KB

BloodMove, SA

The Country Health South Australia Local Health Network (CHSA) BloodMove Project is a collaborative program to facilitate best practice in blood management throughout regional South Australia. BloodMove oversees 60 regional hospitals that are supplied with blood and blood products by both regional and metropolitan transfusion services. Since its commencement, BloodMove has sustained and further improved upon reduction of avoidable blood wastage in CHSA - from 15% in July 2007 to less than 1% in January 2013.

See the case study here: 

  • Better Practice Case Study - BloodMove
    475.2 KB

BloodMove Platelets, SA

The BloodMove Platelets project aimed to reduce platelet wastage rates due to expiry. The project involves a collaborative platelet inventory concept comprising of moving Day 4 platelet blood stocks from low usage sites to high usage sites and then sharing a common multi-site near expiry Day 5 platelet inventory. With this collaboration and minor inventory level and dispatch practices changes, platelet wastage rates have reduced from highs of up 21% down to 6%.

See the case study here:

  • Better Practice Case Study - BloodMove Platelets
    1.18 MB

Liverpool Hospital, NSW

Prior to December 2013 Liverpool Hospital used a paper-based sign-out register for logging blood products in and out of their operating theatre fridge. This register was often not completed or inaccurate. As a result staff could not be confident that unused red blood cells had been returned to the fridge within a 30 minute window thereby ensuring it was safe to reissue. There was also the additional risk that blood removed from the operating theatre fridge for transfusion could go to the wrong patient. These risks were seen as unacceptable and in an effort to reduce these risks, the hospital transfusion service implemented the use of Radio Frequency Identification (RFID) tags to track the intra-hospital movement of their blood and blood products with the aim of improving patient safety.

See the case study here:

  • Better Practice Case Study: Liverpool Hospital RFID Case Study
    627.01 KB

Burnside War Memorial Hospital, SA

Burnside War Memorial Hospital in South Australia recently reviewed its perioperative red blood cell ordering practices. The resulting implemented changes have allowed this not-for-profit community-based hospital to successfully reduce blood bag handling, improve patient safety and free up nurses for patient care. In addition, Burnside Hospital is well on its way to meeting the National Safety and Quality Health Service Blood Management Standard.

See the case study here:

  • Better Practice Case Study - Burnside War Memorial Hospital
    943.82 KB

The Royal Children's Hospital Melbourne Extended Life Plasma Protocol

The Royal Children’s Hospital, Melbourne introduced the use of Extended Life Plasma (ELP) following extensive in-house safety and efficacy testing. As a result of implementing an ELP protocol, the laboratory at the Royal Children’s Hospital can not only provide thawed plasma in a timely manner but has also significantly reduced the wastage of unused thawed fresh frozen plasma across all clinical areas.

See the case study here:

  • Better Practice Case Study - The Royal Children's Hospital Melbourne Extended Life Plasma Protocol
    271.89 KB

Patient Blood Management

Point of Care Coagulation Testing Case Study The Prince Charles Hospital Brisbane

This case study illustrates efforts undertaken by clinical staff at The Prince Charles Hospital in detecting, managing and monitoring critical bleeding in cardiac surgery patients through the use of Point of Care Coagulation Testing.

See the case study here: 

  • Point of Care Coagulation Testing Case Study The Prince Charles Hospital Brisbane
    4.49 MB

Small volume tubes at Flinders Medical Centre, SA

Hospital acquired anaemia or iatrogenic anaemia is anaemia that results from blood loss due to repeated blood sample collection (phlebotomy), of hospitalised patients for the purpose of diagnostic testing. This case study illustrates the implementation of the introduction of small volume sample tubes at the Flinders Medical Centre intensive care unit, which significantly reduced iatrogenic blood loss due to diagnostic testing without adversely affecting the laboratory workflow.

See the case study here: 

  • Small volume tubes at Flinders Medical Centre, SA
    438.2 KB

Preoperative anaemia identification, assessment and management case study

The preoperative anaemia identification, assessment and management case study is intended to inform healthcare practitioners, health educators, health service managers and policy makers about preoperative anaemia screening. This resource provides a wealth of ideas and links to help hospitals use clinical practice improvement methods to implement an anaemia screening clinic based on evidence-based recommendations in the Patient Blood Management Guidelines: Module 2 – Perioperative.

See the case study here: 

  • Preoperative anaemia identification, assessment and management case study
    2.61 MB

Further Case Studies

The NBA is developing case studies on an ongoing basis. If you have a suggestion for either a general topic, or a specific example for a case study, please contact support@blood.gov.au(Opens in a new tab/window).

Last updated: 24 Sep 2024

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback